Addus HomeCare Co. (NASDAQ:ADUS) EVP Cliff Donald Blessing Sells 178 Shares

Addus HomeCare Co. (NASDAQ:ADUS) EVP Cliff Donald Blessing sold 178 shares of the business’s stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $101.17, for a total transaction of $18,008.26. Following the completion of the sale, the executive vice president now owns 10,401 shares in the company, valued at approximately $1,052,269.17. This trade represents a 1.68 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Addus HomeCare Trading Up 0.8 %

Shares of NASDAQ ADUS opened at $98.04 on Wednesday. Addus HomeCare Co. has a one year low of $87.88 and a one year high of $136.72. The business has a 50-day moving average price of $98.76 and a two-hundred day moving average price of $116.65. The firm has a market capitalization of $1.78 billion, a PE ratio of 22.43, a PEG ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Research analysts anticipate that Addus HomeCare Co. will post 4.59 EPS for the current year.

Analysts Set New Price Targets

A number of analysts recently weighed in on ADUS shares. JMP Securities restated a “market outperform” rating and set a $150.00 target price on shares of Addus HomeCare in a report on Tuesday. Macquarie reissued an “outperform” rating and set a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 27th. Oppenheimer lifted their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. StockNews.com downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Finally, Stephens reissued an “overweight” rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $132.78.

Hedge Funds Weigh In On Addus HomeCare

Institutional investors and hedge funds have recently modified their holdings of the stock. Woodmont Investment Counsel LLC purchased a new stake in shares of Addus HomeCare during the first quarter worth $1,835,000. Janney Montgomery Scott LLC grew its stake in Addus HomeCare by 6.7% in the first quarter. Janney Montgomery Scott LLC now owns 11,402 shares of the company’s stock valued at $1,128,000 after purchasing an additional 711 shares in the last quarter. Exchange Traded Concepts LLC increased its position in Addus HomeCare by 219.4% in the 1st quarter. Exchange Traded Concepts LLC now owns 18,921 shares of the company’s stock worth $1,871,000 after purchasing an additional 12,998 shares during the last quarter. Vista Finance LLC raised its stake in shares of Addus HomeCare by 7.0% during the 1st quarter. Vista Finance LLC now owns 2,994 shares of the company’s stock worth $296,000 after purchasing an additional 195 shares in the last quarter. Finally, Azzad Asset Management Inc. ADV lifted its holdings in shares of Addus HomeCare by 14.1% during the 1st quarter. Azzad Asset Management Inc. ADV now owns 10,086 shares of the company’s stock valued at $997,000 after buying an additional 1,247 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.